All lenacapavir articles
-
NewsNew therapy may effectively control HIV in Uganda
Clinical trials showed an effective antiviral drug, known as lenacapavir, against HIV in Uganda, and has also been tested for drug resistance in different subtype strains.
-
NewsBreakthrough of the Year: A drug that prevents HIV infection, providing six months of protection per shot
As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir – a promising new injectable drug that prevents HIV infection. The award also recognizes related work surrounding gaining a new understanding of the structure and function of HIV’s capsid protein.
-
NewsResearch reveals how lenacapavir pushes HIV capsid to breaking point
Researchers have uncovered the details of how the novel drug lenacapavir works to stop the virus in its tracks. The molecular mechanisms that they uncovered could help to refine and design more effective anti-viral therapies.
-
NewsCalibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care